II-VI Incorporated (NASDAQ:IIVI) has been assigned an average rating of “Buy” from the seven ratings firms that are covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average twelve-month price target among brokers that have issued a report on the stock in the last year is $40.19.

IIVI has been the topic of several research analyst reports. Zacks Investment Research cut shares of II-VI from a “strong-buy” rating to a “hold” rating in a report on Tuesday, March 28th. Benchmark Co. restated a “buy” rating and set a $40.00 price target on shares of II-VI in a report on Tuesday, July 4th. ValuEngine upgraded shares of II-VI from a “hold” rating to a “buy” rating in a report on Thursday, June 1st. BidaskClub upgraded shares of II-VI from a “sell” rating to a “hold” rating in a report on Thursday, June 15th. Finally, Needham & Company LLC restated a “buy” rating and set a $38.00 price target (down from $40.00) on shares of II-VI in a report on Wednesday, May 3rd.

COPYRIGHT VIOLATION NOTICE: “II-VI Incorporated (IIVI) Receives $40.19 Consensus PT from Brokerages” was first reported by Watch List News and is the property of of Watch List News. If you are reading this piece on another website, it was stolen and reposted in violation of U.S. & international copyright and trademark law. The correct version of this piece can be read at https://www.watchlistnews.com/ii-vi-incorporated-iivi-receives-40-19-consensus-pt-from-brokerages/1443096.html.

Shares of II-VI (NASDAQ IIVI) traded up 1.59% on Tuesday, hitting $38.25. The company had a trading volume of 390,046 shares. II-VI has a 12-month low of $19.37 and a 12-month high of $41.10. The company has a market cap of $2.41 billion, a price-to-earnings ratio of 31.85 and a beta of 0.05. The company has a 50 day moving average of $32.52 and a 200-day moving average of $33.48.

II-VI (NASDAQ:IIVI) last posted its quarterly earnings data on Tuesday, May 2nd. The scientific and technical instruments company reported $0.35 earnings per share for the quarter, topping the consensus estimate of $0.32 by $0.03. II-VI had a net margin of 8.19% and a return on equity of 12.49%. The firm had revenue of $245 million for the quarter, compared to analysts’ expectations of $240.55 million. During the same period in the previous year, the company posted $0.35 EPS. The company’s quarterly revenue was up 19.5% compared to the same quarter last year. On average, analysts forecast that II-VI will post $1.33 earnings per share for the current year.

In other news, VP David G. Wagner sold 4,444 shares of the business’s stock in a transaction on Monday, July 10th. The shares were sold at an average price of $36.00, for a total transaction of $159,984.00. Following the transaction, the vice president now directly owns 45,284 shares in the company, valued at approximately $1,630,224. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Wendy F. Dicicco sold 2,500 shares of the business’s stock in a transaction on Friday, April 28th. The shares were sold at an average price of $33.19, for a total transaction of $82,975.00. Following the transaction, the director now owns 33,046 shares in the company, valued at $1,096,796.74. The disclosure for this sale can be found here. Insiders own 6.80% of the company’s stock.

Institutional investors have recently bought and sold shares of the stock. Quadrature Capital Ltd acquired a new stake in shares of II-VI during the fourth quarter worth about $233,000. Russell Investments Group Ltd. acquired a new stake in shares of II-VI during the fourth quarter worth about $3,094,000. Legato Capital Management LLC boosted its stake in shares of II-VI by 3,505.0% in the first quarter. Legato Capital Management LLC now owns 68,279 shares of the scientific and technical instruments company’s stock worth $1,894,000 after buying an additional 66,385 shares in the last quarter. ClariVest Asset Management LLC boosted its stake in shares of II-VI by 14.6% in the first quarter. ClariVest Asset Management LLC now owns 236,915 shares of the scientific and technical instruments company’s stock worth $8,540,000 after buying an additional 30,100 shares in the last quarter. Finally, Macquarie Group Ltd. acquired a new stake in shares of II-VI during the fourth quarter worth about $8,923,000. Institutional investors and hedge funds own 78.37% of the company’s stock.

About II-VI

II-VI Incorporated develops and manufactures engineered materials, optoelectronic components and products. The Company has three segments: II-VI Laser Solutions, II-VI Photonics and II-VI Performance Products. The II-VI Laser Solutions segment designs, manufactures and markets optical and electro-optical components and materials sold under the II-VI Infrared brand name and used in carbon dioxide (CO2) lasers, fiber-delivered beam delivery systems and processing tools and direct diode lasers for industrial lasers sold under the II-VI HIGHYAG and II-VI Laser Enterprise brand names.

Receive News & Ratings for II-VI Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for II-VI Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.